Medicare Program; Request for Nominations to the Advisory Panel on Ambulatory Payment Classification Groups; Extension of Nominations Deadline, 18028-18029 [05-6862]
Download as PDF
<![CDATA[
18028
Federal Register / Vol. 70, No. 67 / Friday, April 8, 2005 / Notices
Additional background information
can be found at: https://www.cdc.gov/
malaria/.
Dated: April 4, 2005.
William P. Nichols,
Director, Procurement and Grants Office,
Centers for Disease Control and Prevention.
[FR Doc. 05–7047 Filed 4–7–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1296–N2]
Medicare Program; Request for
Nominations to the Advisory Panel on
Ambulatory Payment Classification
Groups; Extension of Nominations
Deadline
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice extends the
deadline for nominations of members to
the Advisory Panel on Ambulatory
Payment Classification (APC) Groups
(the Panel). The original request for
nominations was published in the
Federal Register on February 25, 2005.
(70 FR 9336) Six vacancies will exist on
the Panel as of March 31, 2005.
The purpose of the Panel is to review
the APC groups and their associated
weights and to advise the Secretary of
the Department of Health and Human
Services (the Secretary) and the
Administrator of the Centers for
Medicare & Medicaid Services (CMS)
(the Administrator) concerning the
clinical integrity of the APC groups and
their associated weights. The advice
provided by the Panel will be
considered as CMS prepares its annual
updates of the hospital Outpatient
Prospective Payment System (OPPS)
through rulemaking.
The panel was recently rechartered
for a 2-year period through November
21, 2006.
Nominations: Nominations will be
considered if received no later than May
9, 2005. Mail or deliver nominations to
the following address: CMS; Attn: Shirl
Ackerman-Ross, Designated Federal
Officer (DFO), Advisory Panel on APC
Groups; Center for Medicare
Management (CMM), Hospital &
Ambulatory Policy Group (HAPG),
Division of Outpatient Care (DOC); 7500
Security Boulevard, Mail Stop C4–05–
17; Baltimore, MD 21244–1850.
Web site: For additional information
on the APC Panel and updates to the
SUMMARY:
VerDate jul<14>2003
19:00 Apr 07, 2005
Jkt 205001
Panel’s activities, search our Web site at:
https://www.cms.hhs.gov/faca/apc/
default.asp.
Advisory Committees’ Information
Lines: You may also refer to the CMS
Advisory Committee Information
Hotlines at 1–877–449–5659 (toll-free)
or 410–786–9379 (local) for additional
information.
FOR FURTHER INFORMATION CONTACT:
Persons wishing to nominate
individuals to serve on the Panel or to
obtain further information can also
contact Shirl Ackerman-Ross, the DFO,
at APCPanel@cms.hhs.gov or call 410–
786–4474. News media representatives
should contact the CMS Press Office at
202–690–6145.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary is required by section
1833(t)(9)(A) of the Social Security Act
(the Act), as amended and redesignated
by sections 201(h) and 202(a)(2) of the
Medicare, Medicaid, and SCHIP
Balanced Budget Refinement Act of
1999 (BBRA) (Pub. L. 106–113),
respectively, to establish and consult
with an expert, outside advisory panel
on Ambulatory Payment Classification
(APC) groups.
The Panel meets up to three times
annually to review the APC groups and
to provide technical advice to the
Secretary and the Administrator
concerning the clinical integrity of the
groups and their associated weights.
CMS considers the technical advice
provided by the Panel as we prepare the
proposed rule that proposes changes to
the OPPS for the next calendar year.
The Panel may consist of up to 15
representatives who are full-time
employees (not consultants) of Medicare
providers, which are subject to the
OPPS, and a Chair.
The Administrator selects the Panel
membership based upon either selfnominations or nominations submitted
by providers or interested organizations.
The current Panel members are: (The
asterisk [*] indicates a Panel member
whose term expires on March 31, 2005.)
• E.L. Hambrick, M.D., J.D., a CMS
Medical Officer
• Marilyn K. Bedell, M.S., R.N.,
O.C.N.
• Albert Brooks Einstein, Jr., M.D.
• Lee H. Hilborne, M.D.*
• Stephen T. House, M.D.*
• Kathleen P. Kinslow, C.R.N.A.,
Ed.D.*
• Mike Metro, R.N.*
• Sandra J. Metzler, M.B.A., R.H.I.A.
• Gerald V. Naccarelli, M.D.*
• Frank G. Opelka, M.D.
• Louis Potters, M.D.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
• Lou Ann Schraffenberger, M.B.A.,
R.H.I.A.
• Judie S. Snipes, R.N., M.B.A.,
C.H.E.
• Lynn R. Tomascik, R.N., M.S.N.,
C.N.A.A.
• Timothy Gene Tyler, Pharm.D.
• William A. Van Decker, M.D., J.D.*
Panel members serve without
compensation, according to an advance
written agreement; however, travel,
meals, lodging, and related expenses are
reimbursed in accordance with standard
Government travel regulations. CMS has
a special interest for ensuring that
women, minorities, and the physically
challenged are adequately represented
on the Panel. CMS further encourages
nominations of qualified candidates
from those groups.
The Secretary, or his designee,
appoints new members to the Panel
from among those candidates
determined to have the required
expertise. New appointments are made
in a manner that ensures a balanced
membership.
II. Criteria for Nominees
All nominees must have technical
expertise that enables them to
participate fully in the work of the
Panel. Such expertise encompasses
hospital payment systems, hospital
medical-care delivery systems,
outpatient payment requirements,
Ambulatory Payment Classification
(APC) Groups, Physicians’ Current
Procedural Terminology Codes (CPTs),
the use and payment of drugs and
medical devices in the outpatient
setting, and other forms of relevant
expertise.
It is not necessary for a nominee to
possess expertise in all of the areas
listed, but each must have a minimum
of 5 years experience and currently be
employed full-time in his or her area of
expertise. Members of the Panel serve
overlapping 2, 3, and 4-year terms,
contingent upon the rechartering of the
Panel.
Any interested person may nominate
one or more qualified individuals. Selfnominations will also be accepted. Each
nomination must include a letter of
nomination, the curriculum vita of the
nominee, and a statement from the
nominee that the nominee is willing to
serve on the Panel under the conditions
described in this notice and further
specified in the Charter.
III. Copies of the Charter
To obtain a copy of the Panel’s
Charter, submit a written request to the
DFO at the address provided or by email at APCPanel@cms.hhs.gov, or call
her at 410–786–4474. Copies of the
E:\FR\FM\08APN1.SGM
08APN1
18029
Federal Register / Vol. 70, No. 67 / Friday, April 8, 2005 / Notices
Charter are also available on the Internet
at https://www.cms.hhs.gov/faca.
Authority: Section 1833(t)(9)(A) of the Act
(42 U.S.C. 13951(t)(9)(A). The Panel is
governed by the provisions of Pub. L. 92–463,
as amended (5 U.S.C. Appendix 2).
(Catalog of Federal Domestic Assistance
Program No. 93.774, MedicareSupplementary Medical Insurance Program)
Dated: March 31, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 05–6862 Filed 4–7–05; 8:45 am]
BILLING CODE 4120–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005N–0564]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Temporary
Marketing Permit Applications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by May 9,
2005.
ADDRESSES: OMB is still experiencing
significant delays in the regular mail,
including first class and express mail,
and messenger deliveries are not being
accepted. To ensure that comments on
the information collection are received,
OMB recommends that comments be
faxed to the Office of Information and
Regulatory Affairs, OMB, Attn: Fumie
Yokota, Desk Officer for FDA, FAX:
202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Peggy Robbins, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–1223.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Temporary Marketing Permit
Applications—21 CFR 130.17(c) and (i)
(OMB Control Number 0910–0133)—
Extension
Section 401 of the Federal Food, Drug,
and Cosmetic Act (the act) (21 U.S.C.
341), directs FDA to issue regulations
establishing definitions and standards of
identity for food ‘‘[w]henever * * *
such action will promote honesty and
fair dealing in the interest of consumers
* * * ’’. Under section 403(g) of the act
(21 U.S.C. 343(g)), a food that is subject
to a definition and standard of identity
prescribed by regulation is misbranded
if it does not conform to such definition
and standard of identity. Section 130.17
(21 CFR 130.17) provides for the
issuance by FDA of temporary
marketing permits that enable the food
industry to test consumer acceptance
and measure the technological and
commercial feasibility in interstate
commerce of experimental packs of food
that deviate from applicable definitions
and standards of identity. Section
130.17(c) enables the agency to monitor
the manufacture, labeling, and
distribution of experimental packs of
food that deviate from applicable
definitions and standards of identity.
The information so obtained can be
used in support of a petition to establish
or amend the applicable definition or
standard of identity to provide for the
variations. Section 130.17(i) specifies
the information that a firm must submit
to FDA to obtain an extension of a
temporary marketing permit.
In the Federal Register of January 13,
2005 (70 FR 2411), FDA published a 60day notice requesting public comment
on the information collection
provisions. No comments were received.
FDA estimates the burden of the
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
Number of Respondents
21 CFR section
Annual Frequency per
Response
Total Annual
Responses
Hours per
Response
Total hours
130.17(c)
3
2
6
25
150
130.17(i)
4
2
8
2
16
Total
1There
166
are no capital costs or operating and maintenance costs associated with this collection of information.
The estimated number of temporary
marketing permit applications and
hours per response is an average based
on the agency’s experience with
applications received October 1, 2001,
through September 30, 2004, and
information from firms that have
submitted recent requests for temporary
marketing permits.
Dated: April 1, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05–7021 Filed 4–7–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N–0565]
Food and Drug Administration,
HHS.
ACTION:
BILLING CODE 4160–01–S
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
VerDate jul<14>2003
19:00 Apr 07, 2005
Jkt 205001
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Fax written comments on the
collection of information by May 9,
2005.
DATES:
Agency Information Collection
Activities; Submission for Office of
Managment and Budget Review;
Comment Request; State Petitions for
Exemption From Preemption
AGENCY:
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
OMB is still experiencing
significant delays in the regular mail,
including first class and express mail,
and messenger deliveries are not being
accepted. To ensure that comments on
the information collection are received,
OMB recommends that comments be
faxed to the Office of Information and
Regulatory Affairs, OMB, Attn: Fumie
ADDRESSES:
E:\FR\FM\08APN1.SGM
08APN1
]]>Agencies
[Federal Register Volume 70, Number 67 (Friday, April 8, 2005)]
[Notices]
[Pages 18028-18029]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6862]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1296-N2]
Medicare Program; Request for Nominations to the Advisory Panel
on Ambulatory Payment Classification Groups; Extension of Nominations
Deadline
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice extends the deadline for nominations of members to
the Advisory Panel on Ambulatory Payment Classification (APC) Groups
(the Panel). The original request for nominations was published in the
Federal Register on February 25, 2005. (70 FR 9336) Six vacancies will
exist on the Panel as of March 31, 2005.
The purpose of the Panel is to review the APC groups and their
associated weights and to advise the Secretary of the Department of
Health and Human Services (the Secretary) and the Administrator of the
Centers for Medicare & Medicaid Services (CMS) (the Administrator)
concerning the clinical integrity of the APC groups and their
associated weights. The advice provided by the Panel will be considered
as CMS prepares its annual updates of the hospital Outpatient
Prospective Payment System (OPPS) through rulemaking.
The panel was recently rechartered for a 2-year period through
November 21, 2006.
Nominations: Nominations will be considered if received no later
than May 9, 2005. Mail or deliver nominations to the following address:
CMS; Attn: Shirl Ackerman-Ross, Designated Federal Officer (DFO),
Advisory Panel on APC Groups; Center for Medicare Management (CMM),
Hospital & Ambulatory Policy Group (HAPG), Division of Outpatient Care
(DOC); 7500 Security Boulevard, Mail Stop C4-05-17; Baltimore, MD
21244-1850.
Web site: For additional information on the APC Panel and updates
to the Panel's activities, search our Web site at: https://
www.cms.hhs.gov/faca/apc/default.asp.
Advisory Committees' Information Lines: You may also refer to the
CMS Advisory Committee Information Hotlines at 1-877-449-5659 (toll-
free) or 410-786-9379 (local) for additional information.
FOR FURTHER INFORMATION CONTACT: Persons wishing to nominate
individuals to serve on the Panel or to obtain further information can
also contact Shirl Ackerman-Ross, the DFO, at APCPanel@cms.hhs.gov or
call 410-786-4474. News media representatives should contact the CMS
Press Office at 202-690-6145.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary is required by section 1833(t)(9)(A) of the Social
Security Act (the Act), as amended and redesignated by sections 201(h)
and 202(a)(2) of the Medicare, Medicaid, and SCHIP Balanced Budget
Refinement Act of 1999 (BBRA) (Pub. L. 106-113), respectively, to
establish and consult with an expert, outside advisory panel on
Ambulatory Payment Classification (APC) groups.
The Panel meets up to three times annually to review the APC groups
and to provide technical advice to the Secretary and the Administrator
concerning the clinical integrity of the groups and their associated
weights. CMS considers the technical advice provided by the Panel as we
prepare the proposed rule that proposes changes to the OPPS for the
next calendar year.
The Panel may consist of up to 15 representatives who are full-time
employees (not consultants) of Medicare providers, which are subject to
the OPPS, and a Chair.
The Administrator selects the Panel membership based upon either
self-nominations or nominations submitted by providers or interested
organizations.
The current Panel members are: (The asterisk [*] indicates a Panel
member whose term expires on March 31, 2005.)
E.L. Hambrick, M.D., J.D., a CMS Medical Officer
Marilyn K. Bedell, M.S., R.N., O.C.N.
Albert Brooks Einstein, Jr., M.D.
Lee H. Hilborne, M.D.*
Stephen T. House, M.D.*
Kathleen P. Kinslow, C.R.N.A., Ed.D.*
Mike Metro, R.N.*
Sandra J. Metzler, M.B.A., R.H.I.A.
Gerald V. Naccarelli, M.D.*
Frank G. Opelka, M.D.
Louis Potters, M.D.
Lou Ann Schraffenberger, M.B.A., R.H.I.A.
Judie S. Snipes, R.N., M.B.A., C.H.E.
Lynn R. Tomascik, R.N., M.S.N., C.N.A.A.
Timothy Gene Tyler, Pharm.D.
William A. Van Decker, M.D., J.D.*
Panel members serve without compensation, according to an advance
written agreement; however, travel, meals, lodging, and related
expenses are reimbursed in accordance with standard Government travel
regulations. CMS has a special interest for ensuring that women,
minorities, and the physically challenged are adequately represented on
the Panel. CMS further encourages nominations of qualified candidates
from those groups.
The Secretary, or his designee, appoints new members to the Panel
from among those candidates determined to have the required expertise.
New appointments are made in a manner that ensures a balanced
membership.
II. Criteria for Nominees
All nominees must have technical expertise that enables them to
participate fully in the work of the Panel. Such expertise encompasses
hospital payment systems, hospital medical-care delivery systems,
outpatient payment requirements, Ambulatory Payment Classification
(APC) Groups, Physicians' Current Procedural Terminology Codes (CPTs),
the use and payment of drugs and medical devices in the outpatient
setting, and other forms of relevant expertise.
It is not necessary for a nominee to possess expertise in all of
the areas listed, but each must have a minimum of 5 years experience
and currently be employed full-time in his or her area of expertise.
Members of the Panel serve overlapping 2, 3, and 4-year terms,
contingent upon the rechartering of the Panel.
Any interested person may nominate one or more qualified
individuals. Self-nominations will also be accepted. Each nomination
must include a letter of nomination, the curriculum vita of the
nominee, and a statement from the nominee that the nominee is willing
to serve on the Panel under the conditions described in this notice and
further specified in the Charter.
III. Copies of the Charter
To obtain a copy of the Panel's Charter, submit a written request
to the DFO at the address provided or by e-mail at
APCPanel@cms.hhs.gov, or call her at 410-786-4474. Copies of the
[[Page 18029]]
Charter are also available on the Internet at https://www.cms.hhs.gov/
faca.
Authority: Section 1833(t)(9)(A) of the Act (42 U.S.C.
13951(t)(9)(A). The Panel is governed by the provisions of Pub. L.
92-463, as amended (5 U.S.C. Appendix 2).
(Catalog of Federal Domestic Assistance Program No. 93.774,
Medicare-Supplementary Medical Insurance Program)
Dated: March 31, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 05-6862 Filed 4-7-05; 8:45 am]
BILLING CODE 4120-03-P
